Skip to main content
ARS Home » Research » Publications at this Location » Publication #341499
Research Project: Rift Valley Fever Pathogenesis, Epidemiology, and Control Measures

Location: Location not imported yet.

Title: Incorporation of antigens from whole cell lysates and purified virions from MP12 into fluorescence microsphere immunoassays for the detection of antibodies against Rift Valley fever virus

Author
item HOSSAIN, MOHAMMAD - Kansas State University
item Wilson, William
item ROWLAND, RAYMOND - Kansas State University

Submitted to: Virology Journal
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: 3/15/2017
Publication Date: 4/2/2017
Citation: Hossain, M.M., Wilson, W.C., Rowland, R.R. 2017. Incorporation of antigens from whole cell lysates and purified virions from MP12 into fluorescence microsphere immunoassays for the detection of antibodies against Rift Valley fever virus. Virology Journal. 1:24-31.

Interpretive Summary: This study was the developed of multiplex immunoassay for the detection of two classes of antibodies to Rift Valley fever virus (RVFV) using whole cell lysates and purified virus from a vaccine strain MP12 attached to fluorescent microspheres. The experimental results demonstrated that the incorporation of these preparations into this fluorescence microsphere immunoassay (FMIA) provides an improved sensitivity and specificity of serological assay with internal confirmation (i.e. multiple antigen targets) thus providing advantages over the traditional ELISA.

Technical Abstract: Background: The purpose of this study was the development of multiplex fluorescence microsphere immunoassay (FMIA) for the detection of Rift Valley fever virus (RVFV) IgG and IgM antibodies by incorporation of antigens from whole cell lysates and purified virions from MP12. Methods and Findings: Viral antigens were derived from whole cell material prepared from BHK cells infected with MP-12 (C-MP12). Virions from cell-free culture supernatant were purified on a sucrose cushion (V-MP12). The antigen material was treated with Triton X-100 or NP-40 prior to coating onto Luminex beads. V-MP12 and C-MP12 were assembled into a multiplex and tested in sheep and cattle infected with wild-type RVFV and the vaccine strain MP12. In these studies, V-MP12, C-MP12, and recombinant antigens (Gn, NSs, NSm, N) conjugated beads used in multiplex FMIA and the maximum level of IgG response to sheep in V-MP12 was recorded. IgG reactivity for the antigen targets varied with V-MP12>C-MP12. The positivity-negativity were evaluated by calculating S/P ratio using serum from RVFV-negative sheep (n=100) and negative cattle (n=100). The reaction of monoclonal anti-RVFV N antibody has been tested against N, V-MP12, and CMP12 by FMIA and all the antigens were reactive to antibody N>V-MP12>C-MP12. Conclusions: The experimental results demonstrate that the incorporation of V-MP12 and/or C-MP12 in the FMIA provides an improved sensitivity and specificity of FMIA with internal confirmation (i.e. multiple antigen targets) thus providing advantages over the traditional ELISA.